These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
242 related items for PubMed ID: 16199640
1. Use of the levonorgestrel-releasing intrauterine system and breast cancer. Backman T, Rauramo I, Jaakkola K, Inki P, Vaahtera K, Launonen A, Koskenvuo M. Obstet Gynecol; 2005 Oct; 106(4):813-7. PubMed ID: 16199640 [Abstract] [Full Text] [Related]
2. Comparison of metabolic and inflammatory outcomes in women who used oral contraceptives and the levonorgestrel-releasing intrauterine device in a general population. Morin-Papunen L, Martikainen H, McCarthy MI, Franks S, Sovio U, Hartikainen AL, Ruokonen A, Leinonen M, Laitinen J, Järvelin MR, Pouta A. Am J Obstet Gynecol; 2008 Nov; 199(5):529.e1-529.e10. PubMed ID: 18533124 [Abstract] [Full Text] [Related]
3. Levonorgestrel-releasing and copper intrauterine devices and the risk of breast cancer. Dinger J, Bardenheuer K, Minh TD. Contraception; 2011 Mar; 83(3):211-7. PubMed ID: 21310281 [Abstract] [Full Text] [Related]
4. Cancer risk in women using the levonorgestrel-releasing intrauterine system in Finland. Soini T, Hurskainen R, Grénman S, Mäenpää J, Paavonen J, Pukkala E. Obstet Gynecol; 2014 Aug; 124(2 Pt 1):292-299. PubMed ID: 25004338 [Abstract] [Full Text] [Related]
5. [Levonorgestrel-releasing intrauterine device (Mirena) and breast cancer: what do we learn from literature for clinical practice?]. Boutet G. Gynecol Obstet Fertil; 2006 Nov; 34(11):1015-23. PubMed ID: 17092752 [Abstract] [Full Text] [Related]
6. Use of the levonorgestrel-releasing intrauterine system and breast cancer. Tjalma WA, Trinh XB, van Dam PA. Obstet Gynecol; 2006 Jan; 107(1):207-8; author reply 208. PubMed ID: 16394064 [No Abstract] [Full Text] [Related]
13. Intrauterine devices: an effective alternative to oral hormonal contraception. Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436 [Abstract] [Full Text] [Related]
14. Clinical performance of a levonorgestrel-releasing intrauterine system and oral contraceptives in young nulliparous women: a comparative study. Suhonen S, Haukkamaa M, Jakobsson T, Rauramo I. Contraception; 2004 May; 69(5):407-12. PubMed ID: 15105064 [Abstract] [Full Text] [Related]
17. [Hormone therapy and risk for breast cancer in Finnish postmenopausal women]. Lyytinen H, Ylikorkala O. Duodecim; 2011 May; 127(3):235-42. PubMed ID: 21438346 [Abstract] [Full Text] [Related]
19. Serum levonorgestrel levels and endometrial thickness during extended use of the levonorgestrel-releasing intrauterine system. Hidalgo MM, Hidalgo-Regina C, Bahamondes MV, Monteiro I, Petta CA, Bahamondes L. Contraception; 2009 Jul; 80(1):84-9. PubMed ID: 19501221 [Abstract] [Full Text] [Related]
20. [Abdominal migration of a levonorgestrel-releasing intrauterine device. Case report and review of the literature]. Pont M, Lantheaume S. J Gynecol Obstet Biol Reprod (Paris); 2009 Apr; 38(2):179-81. PubMed ID: 19303222 [Abstract] [Full Text] [Related] Page: [Next] [New Search]